- Home
- KROS vs VATE Comparison
KROS vs VATE Comparison
Compare KROS & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | VATE |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.3M | 207.8M |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | KROS | VATE |
|---|---|---|
| Price | $10.05 | $17.30 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.86 | N/A |
| AVG Volume (30 Days) | ★ 282.7K | 63.4K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $243,864,000.00 | ★ $1,246,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,751.79 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 12.55 |
| 52 Week Low | $9.79 | $3.75 |
| 52 Week High | $22.55 | $19.59 |
Technical Indicators
Market Signals| Indicator | KROS | VATE |
|---|---|---|
| Relative Strength Index (RSI) | 38.63 | 61.74 |
| Support Level | $9.79 | $4.48 |
| Resistance Level | $12.43 | N/A |
| Average True Range (ATR) | 0.45 | 1.66 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 20.62 | 64.12 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.